Cargando…
Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway
OBJECTIVES: We investigated how the prognosis for Norwegian patients with stage IV, adenocarcinoma (NSCLC) has developed during the last decade, to observe if increased survival coincides with the introduction of immunotherapy at a population level. MATERIALS AND METHODS: Incidence data from the Can...
Autores principales: | Børø, Siri, Thoresen, Steinar, Helland, Åslaug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745181/ https://www.ncbi.nlm.nih.gov/pubmed/36523970 http://dx.doi.org/10.3389/fonc.2022.1017902 |
Ejemplares similares
-
COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
por: Johannesen, Tom Børge, et al.
Publicado: (2021) -
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
por: Khadse, Anand, et al.
Publicado: (2022) -
Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway
por: Botteri, Edoardo, et al.
Publicado: (2017) -
Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients
por: Halvorsen, Ann Rita, et al.
Publicado: (2020) -
Healthcare to parents of young terrorism survivors: a registry-based study in Norway
por: Haga, Jon Magnus, et al.
Publicado: (2017)